Your browser doesn't support javascript.
Hospitalist perspectives on barriers to recommend and potential benefit of the COVID-19 vaccine.
Dugani, Sagar B; Geyer, Holly L; Maniaci, Michael J; Fischer, Karen M; Croghan, Ivana T; Coons, Trevor J; Canan, Elizabeth L; Burton, M Caroline.
  • Dugani SB; Division of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Geyer HL; Division of Hospital Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA.
  • Maniaci MJ; Division of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Fischer KM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Croghan IT; Department of Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Coons TJ; Robert D. And Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
  • Canan EL; Department of Medicine, Clinical Research Office, Mayo Clinic, Rochester, MN, USA.
  • Burton MC; Division of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Hosp Pract (1995) ; 49(4): 245-251, 2021 Oct.
Article in English | MEDLINE | ID: covidwho-1171276
ABSTRACT

Background:

Hospitalists, comprised of nurse practitioners and physician assistants (collectively, advanced practice providers [APPs]) and physicians, have opportunities to counsel patients and reduce SARS-CoV-2 related coronavirus disease 2019 (COVID-19) vaccine hesitancy. However, hospitalist perspectives on the COVID-19 vaccine and potential differences between APPs and physicians are unknown. Understanding hospitalist perspectives could help to address vaccine hesitancy among patients.

Methods:

We conducted an online survey of hospitalists at Mayo Clinic sites in Arizona, Florida, Minnesota, and Wisconsin from 14 December 2020 through 4 January 2021. We collected demographic information and assessed perspectives on the COVID-19 vaccine and, for comparison, on the influenza vaccine. Descriptive statistics were used to compare responses between APPs and physicians.

Results:

The overall response rate was 42.7% (n = 128/300) and comprised of 53.9% women (n = 69/128) and 41.4% APPs (n = 53/128). Most hospitalists reported receiving or planning to receive vaccination against COVID-19 (93.7%; n = 119/128) and influenza (97.7%; n = 125/128). Most hospitalists reported they would advise 100% of patients to receive the COVID-19 vaccine (66% for APPs; 74.7% for physicians) and influenza vaccine (83% for APPs; 80% for physicians). Barriers to recommending the COVID-19 vaccine included patient health status and vaccine safety profile. Hospitalists reported that patients and coworkers receiving the COVID-19 vaccine would reduce their anxiety (~80% of hospitalists), social isolation (~64% of hospitalists), and improve their emotional support (~40% of hospitalists). APP and physician responses were similar. The possible reduction in social isolation was associated with higher odds of hospitalists advising all patients to receive the COVID-19 vaccine (adjusted odds ratio 2.95 [95% confidence interval, 1.32-6.59]; P< .008), whereas hospitalist age, gender, and profession showed no association.

Conclusion:

Most hospitalists would reportedly advise patients to receive the COVID-19 vaccine. Barriers to this recommendation included patient health status and vaccine safety. Hospitalists are an important resource to provide patient education and reduce COVID-19 vaccine hesitancy.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Hospitalists / Influenza, Human / COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Hosp Pract (1995) Journal subject: Hospitals Year: 2021 Document Type: Article Affiliation country: 21548331.2021.1914465

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Hospitalists / Influenza, Human / COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Hosp Pract (1995) Journal subject: Hospitals Year: 2021 Document Type: Article Affiliation country: 21548331.2021.1914465